Disease-modifying medications are an integral part of every multiple sclerosis treatment plan. These drugs work to control multiple sclerosis attacks, improve symptoms, and enhance the overall quality of life of MS patients.
Disease-modifying drugs are the most effective approach to slow down the progression of the disease. While these drugs do not necessarily better the condition of MS patients fully, their long-term benefits are countless.
Numerous clinical trials have shown that disease-modifying drugs can:
- Decrease the frequency and intensity of MS relapses in individuals with relapsing types of multiple sclerosis, secondary progressive MS included
- Inhibit the formation of new lesions in the central nervous system
- Reduce or limit the progression of disability
Indeed, research reveals that early treatment with disease-modifying drugs can go a long way in preventing long-term damage to the brain and spinal cord. This is because nerve fibres become permanently impaired in the early stages of MS due to the attack on myelin.
Out of numerous options, glatiramer acetate, available under the brand name Copaxone and manufactured by Teva Neuroscience, is one of the primary choices for treating relapsing-remitting multiple sclerosis.
Copaxone Multiple Sclerosis Treatments
The primary role of Copaxone multiple sclerosis treatments is to decrease the severity and frequency of MS attacks in individuals with relapsing-remitting MS. The active ingredient of the medication is glatiramer acetate, a man-made protein that regulates the immune response associated with MS, though its precise action remains unknown.
Copaxone is taken intravenously either once on a daily basis or three times every week. According to the results of the clinical trials, Copaxone lowers the incidence rate of attacks and reduces damage to nerves in individuals with RRMS.
Additionally, glatiramer acetate has also been linked to a drastic decrease in the development of new lesions in the brain.
The most common side effects that Copaxone can cause include rashes, trouble breathing, chest pressure, and skin reactions, such as itching and irritation, on injection sites. Some individuals on Copaxone also experience chest pain, increased heart rate, difficulty breathing, and anxiety.
Finally, as opposed to most MS medications such as interferons, glatiramer acetate does not cause flu-like side effects, mood changes, or lethargy.
Featured Image: DepositPhotos/ BrianAJackson